We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

175 hedge funds and large institutions have $1.37B invested in Imperva, Inc. in 2017 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 59 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

24% more call options, than puts

Call options by funds: $6.64M | Put options by funds: $5.36M

14% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 28

2% more funds holding

Funds holding: 171175 (+4)

3% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 59

5% less capital invested

Capital invested by funds: $1.44B → $1.37B (-$71.1M)

Holders
175
Holders Change
+4
Holders Change %
+2.34%
% of All Funds
3.97%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
32
Increased
61
Reduced
59
Closed
28
Calls
$6.64M
Puts
$5.36M
Net Calls
+$1.29M
Net Calls Change
-$3.01M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$12.3M +$6.17M +148,077 +92%
EMFAT
27
Emerald Mutual Fund Advisers Trust
Pennsylvania
$11.3M -$10.6M -253,359 -47%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$11.3M +$625K +14,998 +6%
Fidelity International
29
Fidelity International
Bermuda
$11.2M
ECP
30
Elk Creek Partners
Colorado
$11M +$331K +7,940 +3%
GES
31
GO ETF Solutions
United Kingdom
$11M +$2.52M +60,562 +28%
Morgan Stanley
32
Morgan Stanley
New York
$10.6M +$1.04M +25,051 +10%
Goldman Sachs
33
Goldman Sachs
New York
$10.2M -$781K -18,730 -7%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$9.98M -$952K -22,837 -8%
MWNA
35
Marshall Wace North America
New York
$9.87M +$8.61M +206,705 +494%
First Trust Advisors
36
First Trust Advisors
Illinois
$9.24M -$157K -3,779 -2%
1M
37
13D Management
New York
$7.89M -$2.15M -51,615 -21%
Citadel Advisors
38
Citadel Advisors
Florida
$7.63M -$4.19M -100,528 -34%
Point72 Asset Management
39
Point72 Asset Management
Connecticut
$7.56M +$7.94M +190,424 New
Wells Fargo
40
Wells Fargo
California
$7.4M -$1.15M -27,672 -13%
BA
41
Broadview Advisors
Wisconsin
$6.96M +$500K +12,000 +7%
PAM
42
Panagora Asset Management
Massachusetts
$6.87M -$268K -6,429 -4%
American Century Companies
43
American Century Companies
Missouri
$6.7M +$470K +11,283 +7%
TCIM
44
TIAA CREF Investment Management
New York
$6.55M -$1.18M -28,412 -15%
Charles Schwab
45
Charles Schwab
California
$6.2M +$727K +17,453 +13%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$5.95M
Fisher Asset Management
47
Fisher Asset Management
Washington
$5.89M -$538K -12,903 -8%
Bank of New York Mellon
48
Bank of New York Mellon
New York
$5.81M -$181K -4,345 -3%
TCM
49
Triarii Capital Management
Massachusetts
$5.56M +$5.83M +140,000 New
SCA
50
Secor Capital Advisors
New York
$5.1M +$1.71M +40,919 +47%

IMPV Hedge Fund Activity: Q4 2017 in Review

175 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q4 2017, worth a combined $1.37B — down 4.9% from $1.44B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new IMPV positions and 28 closed out — a net gain of 4 holders — while 61 added to existing stakes and 59 trimmed.

The largest buyer was RGM Capital, opening a new position worth an estimated $53.6M. The largest seller was JP Morgan Chase, cutting an estimated $21.7M.

  • 175 institutional investors held Imperva, Inc. (IMPV) as of Q4 2017, up from 171 in Q3 2017.
  • Funds reported $1.37B of Imperva, Inc. stock for Q4 2017, down 4.9% quarter-over-quarter.
  • 32 funds opened new Imperva, Inc. positions in Q4 2017 and 28 closed out, a net change of +4 holders.
  • The largest Imperva, Inc. buyer in Q4 2017 was RGM Capital, an estimated $53.6M added.
  • The largest Imperva, Inc. seller in Q4 2017 was JP Morgan Chase, an estimated $21.7M sold.

Based on aggregated 13F filings for Q4 2017.